Lv4
500 积分 2025-09-30 加入
Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy
7个月前
已完结
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
7个月前
已完结
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
7个月前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
7个月前
已完结
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
7个月前
已完结
Second Primary Malignancies after CAR T-Cell Therapy: A Systemic Review
8个月前
已完结
Late Effects after Chimeric Antigen Receptor T Cell Therapy for Lymphoid Malignancies
8个月前
已完结
Insertional Mutagenesis: A Powerful Tool in Cancer Research
8个月前
已关闭
T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategies
8个月前
已完结
皖公网安备34019202002308
